跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HALYCIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
HALYCIL
Authorized
STANDARD
HALYCIL
halewood chemicals limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e39a571cfc468930
Company
halewood chemicals limited
Type
Standard
Approval Details
Approval Id
e39a571cfc468930
Drug Approval Canada Name
HALYCIL
Product Name
HALYCIL
Status
Marketed
Status Date
2022-03-23
Original Market Date
2022-03-23
Din
02521059
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:36.08
Atc Original
H03BA02 PROPYLTHIOURACIL
Atc Name
h 03 ba 02
Aig Number
0103603001
Company Name
halewood chemicals limited
Company Address
The Mill, Horton Rd, Stanwell Moor, Staines, --, United Kingdom, TW196BJ
Active Ingredients
PROPYLTHIOURACIL
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e39a571cfc468930
Type
Standard
Back to Health Canada Approvals